Cart
sales@molnova.com
XY028-133
CAS No. 2229974-73-4
XY028-133( —— )
Catalog No. M33174 CAS No. 2229974-73-4
XY028-133 is a PROTAC-based CDK4/6 degrader for the study of tumors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 546 | In Stock |
|
| 5MG | 282 | In Stock |
|
| 10MG | 493 | In Stock |
|
| 25MG | 847 | In Stock |
|
| 50MG | 1460 | In Stock |
|
| 100MG | 2539 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameXY028-133
-
NoteResearch use only, not for human use.
-
Brief DescriptionXY028-133 is a PROTAC-based CDK4/6 degrader for the study of tumors.
-
DescriptionXY028-133 (example 14) is a PROTAC-based CDK4/6 degrader with anti-tumor activity, which consists of ligands for von Hippel-Lindau and CDK.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPROTACs | CDK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2229974-73-4
-
Formula Weight1002.23
-
Molecular FormulaC53H67N11O7S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (49.89 mM; Ultrasonic )
-
SMILESCC(=O)c1c(C)c2cnc(Nc3ccc(cn3)N3CCN(CC3)C(=O)CCCCCC(=O)N[C@H](C(=O)N3C[C@H](O)C[C@H]3C(=O)NCc3ccc(cc3)-c3scnc3C)C(C)(C)C)nc2n(C2CCCC2)c1=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. JIN, Jian， et al. COMPOSITIONS AND METHODS FOR TREATING CDK4/6-MEDIATED CANCER. Patent. US2017/065027.
molnova catalog
related products
-
5-Chloro-2-deoxyurid...
5-Chloro-2'-deoxyuridine is a thymine analog. It can be used to study the potential of hypochlorous acid damage to DNA and DNA precursors.
-
Darutoside
Darutoside can as an appropriate treatment for wounds.
-
α-Factor Mating Pher...
The alpha factor pheromone arrests yeast in the G1 phase of their cell cycle. Alpha Factor Mating Pheromone induces the expression of mating genes, changes in nuclear architecture, and polarzes growth toward the mating partner.
